Could RFK Jr’s move to pull mRNA vaccine funding be a huge miscalculation?

Frank vaccines have been built as a medical miracle that saved lives during the roaming epidemic, but now the United States is retreating from searching for them.

US Health Secretary Robert F. Kennedy Junior canceled 22 projects – at a value of $ 500 million (376 million pounds) in financing – to treat infections such as Covid and FLU.

Does Kennedy – may have the most famous vaccine in the country – a point, or does it make a tremendous miscalculation?

“It is a little bit of both”, but getting rid of “stupid” and possibly “disastrous mistake” technology.

Let’s not penetrate why.

Kennedy says he has been reviewing the sciences on the Rena -messenger vaccines, and concluded that “the data shows that these vaccines fail to protect effectively from upper respiratory infections such as Covid and FLU.”

Instead, he says, he will turn funding into “safer and broader vaccine platforms that are still effective even with the transformation of viruses.”

Are flexible vaccines safe? Is it effective? Will other pollen will be better?

The other question is where the flexible vaccines should be suitable for Pantheon from other vaccine techniques – because there is a lot:

• Broken vaccines Use the original virus or bacteria, kill it, and use it to train the immune system – such as the annual influenza snapshot
• Diverted vaccines Do not kill the gastric worker, but make it weaker to cause a moderate infection – such as the MMR vaccine (measles, mumps and measles)
• Constant vaccines Use parts of protein or sugar from a bug, leading to an immune response without causing an infection – such as meningitis types
• Frank vaccines Use part of the genetic code temporarily that guide the body to make parts of the virus, and the immune system interacts with this

Each of them has advantages and disadvantages, but Professor Finn argues that we are “full -time” vaccines during the epidemic to exclude other methods, and now there is a seizure process.

He says: “But to swing in the pendulum so far until we are useless and have no value and should not be better developed or understood, it is the matter of great things.”

Professor Andrew Pollard of the Oxford vaccine group, which is recommended, is advised by the Chairman of the Joint Equipment and Immunization Committee (JCVI), which recommends the UK government.

It has been shown that vaccines provide protection – keeping people alive and outside the hospital – in both clinical experiences and after extensive monitoring of how vaccines are performed when it was put around the world.

In the first year of vaccination during the roaming epidemic, it was estimated that the Biontech Mrna vaccine alone Almost 6 million life.

Against that there were a small number of cases of heart tissue – called myocarditis – especially in young people.

“The very rare side effects should be balanced with the huge benefit of technology,” says Professor Pollard.

The epidemic was in the afternoon, as the world was one focusing on rationality on Kovid and the offspring was extensively monitored. The consensus remains that they did more quality than harm.

But this does not mean that it is the perfect technique.

Covid vaccines training to target only one protein of the whole virus. If this protein changes in the Coronophone virus or is being conducted, the body protection will be reduced.

We have seen the consequences of this – immunity and vaccines are annoyed to update.

One of the theoretical argument is that the different pollen approach – such as using the entire virus – would give better protection, because the immune system will have more to target.

However, Professor Pollard says that the messenger Rana vaccines are better than those that were activated when dealing with Covid.

He says this may be due to the way it is made – and the fact that the killing of the virus “also changes viral proteins so that there is less motivation for the immune system” compared to the Burns of the Merseuled Rana.

The need to update vaccines is not a failure in MRNA technology that can be easily solved by the axis from one technology to another – instead, it belongs to the basic nature of some viruses.

The same measles or human papillomas vaccines (HPV) were effective for decades and did not show any sign of failure because the genetic symbols of the virus are more stable in each case.

But some viruses live in a permanent flow.

Influenza, for example, is not a single virus – but instead a goal that constantly turns. At any time, one breed will be to climb and be more likely to cause trouble in the winter.

In influenza, the gave flu injection that is given to adults is updated every year – as well as the live vaccine that is given to children like nose. In the future, a flexible form of influenza vaccine will work in the same way.

Professor Pollard says: “The point related to keeping pace with the variables revolves around all technologies, and not only flexible,” says Professor Pollard.

There is a legal scientific question about the technique of vaccine that is used for the disease.

What causes anxiety among scientists is that withdrawing flexible research means that we will not have these vaccines at times when we need to do what no other technology can.

Professor Pollard says: “I don’t think there is evidence that it is much better for protection, but when RNA Tech is on the streets before everything else responds to the outbreak,” says Professor Pollard.

The world is very drilled in making new influenza vaccines every year. But until then, there is a six -month process to decide on the new influenza breeds to target them, and to develop the vaccine on a large scale in chicken eggs and then distribute. New brand vaccines take longer.

But with us, you can get the new vaccine in six to eight weeks, then tens or hundreds of millions of doses after a few months.

Some of the projects that were funded in the United States were preparing for the bird flu pavement. This virus, H5N1, was destroyed by birds and jumps into a wide range of other animals including American livestock.

“This is not logical, and if we get the pandemic of bird flu, it can be considered a catastrophic mistake,” says Professor Vin.

But the repercussions of the United States, which has turned away from flexible research, can be wider.

What is the effect of this step on confidence in current vaccines, flexible or otherwise? How does it affect the world when the United States is one of the most influential countries in medical research? Will it have an effect on other types of messenger technology, such as cancer vaccines – or using the approach to the treatment of rare genetic diseases?

Professor Pollard asks another question after the RFK JR step: “Are we all at risk if it is a huge market that turns its back on the RNA?

“It is one of the most important techniques that we will see in this century in infectious diseases, vital therapeutic factors for a rare disease, and critically for cancer. It is a message that I am concerned.”